STRATA Skin Sciences Inc. has received a deficiency notification from Nasdaq for failing to meet the minimum stockholders’ equity requirement of $2.5 million, as mandated by Nasdaq Listing Rule 5550(b)(1). As a result, the company anticipates delisting from the Nasdaq Capital Market and plans to file forms with the SEC to deregister its common stock and suspend its public reporting obligations, a process known as "going dark." This move is expected to save costs and administrative effort but may reduce the liquidity of its shares and limit stockholders’ ability to sell them easily.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STRATA Skin Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-004822), on February 11, 2026, and is solely responsible for the information contained therein.